American Society of Hirudotherapy

Large scale changes in the transcriptome of Eisenia fetida during regeneration

Research article published in PloS one (2018)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Observational studyGenomics & ProteomicsBhambri A et al. · PloS one, 2018

Abstract

Earthworms show a wide spectrum of regenerative potential with certain species like Eisenia fetida capable of regenerating more than two-thirds of their body while other closely related species, such as Paranais litoralis seem to have lost this ability. Earthworms belong to the phylum Annelida, in which the genomes of the marine oligochaete Capitella telata and the freshwater leech Helobdella robusta have been sequenced and studied. Herein, we report the transcriptomic changes in Eisenia fetida (Indian isolate) during regeneration. Following injury, E. fetida regenerates the posterior segments in a time spanning several weeks. We analyzed gene expression changes both in the newly regenerating cells and in the adjacent tissue, at early (15days post amputation), intermediate (20days post amputation) and late (30 days post amputation) by RNAseq based de novo assembly and comparison of transcriptomes. We also generated a draft genome sequence of this terrestrial red worm using short reads and mate-pair reads. An in-depth analysis of the miRNome of the worm showed that many miRNA gene families have undergone extensive duplications. Sox4, a master regulator of TGF-beta mediated epithelial-mesenchymal transition was induced in the newly regenerated tissue. Genes for several proteins such as sialidases and neurotrophins were identified amongst the differentially expressed transcripts. The regeneration of the ventral nerve cord was also accompanied by the induction of nerve growth factor and neurofilament genes. We identified 315 novel differentially expressed transcripts in the transcriptome, that have no homolog in any other species. Surprisingly, 82% of these novel differentially expressed transcripts showed poor potential for coding proteins, suggesting that novel ncRNAs may play a critical role in regeneration of earthworm.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeComparative StudyJournal ArticleResearch Support, Non-U.S. Gov't
Indexed MeSH termsAnimalsEvolution, MolecularGene Expression ProfilingGene Expression RegulationGene Regulatory NetworksGenomeMicroRNAsMultigene FamilyOligochaetaPhylogenyRegenerationSOXC Transcription Factors

Summary

Large scale changes in the transcriptome of Eisenia fetida during regeneration.

Why This Matters for Hirudotherapy

This study analyzed the large-scale transcriptomic changes during posterior segment regeneration in the earthworm Eisenia fetida following amputation. Researchers used RNAseq to identify differentially expressed genes, including master regulators of epithelial-mesenchymal transition and novel non-coding RNAs, while also generating a draft genome sequence for the worm. Although the abstract mentions the freshwater leech Helobdella robusta genome as a comparative genomic reference within the Annelida phylum, the study itself involves no leeches. Consequently, this research is entirely irrelevant to hirudotherapy, offering no data on leech biology, the leech secretome, or any therapeutic applications.

Citation

Large scale changes in the transcriptome of Eisenia fetida during regeneration

Bhambri A et al. · PloS one, 2018

Added to ASH library: May 27, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.